Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderValproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in ratsNeuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury.What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and TreatmentNeurorestorative effect of urinary bladder matrix-mediated neural stem cell transplantation following traumatic brain injury in rats.A new avenue for lithium: intervention in traumatic brain injury.Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway : scriptaid protects against TBI via AKT.Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanismHistone deacetylase inhibitors for treating a spectrum of diseases not related to cancerHDAC inhibition in lupus models.The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro.HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis.Hdac-mediated control of endochondral and intramembranous ossificationPreservation of the blood brain barrier and cortical neuronal tissue by liraglutide, a long acting glucagon-like-1 analogue, after experimental traumatic brain injury.Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties.Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.Hydroxamate-based histone deacetylase inhibitors can protect neurons from oxidative stress via a histone deacetylase-independent catalase-like mechanism.Lithium reduces BACE1 overexpression, β amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury.Microglia in the TBI brain: The good, the bad, and the dysregulated.Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatmentHistone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injuryEpigenetic changes following traumatic brain injury and their implications for outcome, recovery and therapyHDAC inhibitors in kidney development and disease.Anti-inflammatory Agents: Present and FutureOmega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury.Epigenetics and the modulation of neuroinflammation.The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia.HDAC inhibitors and neurodegeneration: at the edge between protection and damage.Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies.Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.Glial epigenetics in neuroinflammation and neurodegeneration.Low dose of valproate improves motor function after traumatic brain injury.Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats.The expression changes of cystathionine-β-synthase in brain cortex after traumatic brain injury.Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis.Uridine protects against hypoxic-ischemic brain injury by reducing histone deacetylase activity in neonatal rats.Potential immunotherapies for traumatic brain and spinal cord injury.
P2860
Q24626017-08B9D01A-1BD6-486C-93E1-64B92524E4F9Q27324438-AC82DD6B-FC25-4E01-B49A-07CC6676F520Q30524207-8B16EC9B-306D-4ADF-8C24-7183B1A0A9F3Q30959630-63AE6AF4-30C9-4940-B147-1645BF35ADCCQ33724891-084B9B1B-DEA5-4CE5-AC4C-D025E0FBF92AQ33777980-62A500B1-D28A-4C46-B00F-946F3492A81EQ34310319-7D12BF7C-9355-45A0-AE34-EC467FEBC38CQ34810920-BC9896B5-FD87-475A-A962-138D2010772FQ34839640-504FD0E0-A19E-441A-A24A-5CDED4ED09A8Q35016934-18149710-EE36-4071-94AB-41AA4172DC00Q35016981-D18CBA44-557B-49CC-9934-584590C413B2Q35017018-4A737C38-6A38-4D4D-B6D0-D82BEFA9531CQ35157022-644B5710-F787-4433-B47F-821D79BB0BDDQ35556841-C8D62B03-D926-4A50-98ED-B1166BD1C2F0Q35589875-52D7BB38-1631-41EC-8537-45632CEFF88BQ35623461-027C539C-2FA6-4F21-A927-EF8894C12A14Q35682342-0BC9F384-DB28-4B5E-A2F1-7FD7195FB311Q36034427-4F756DD9-CF43-45F3-8913-DBF03A77A776Q36198046-592159CD-8153-4494-B024-44C51BA52F21Q36399682-FEF71FDE-EFF5-4337-B1A2-7676344716C2Q36948933-B9653678-F400-494E-84DD-694D3A417E72Q36967768-6B436887-493C-44CD-86AB-C04AB5CC1E1CQ37025832-F358B0C5-1C8D-40D9-8BAC-AD42FC965021Q37115414-81290D71-6068-44A5-9D82-77A1C996939FQ37118156-5322E154-8EEE-434E-81FD-73D5EED84132Q37150323-2AA2AC7C-BFC6-4F52-BB89-844281798B39Q37249157-568FB19E-9178-47A0-B75E-9DE0339DD3E5Q37637177-73F9EE48-89F2-450F-BD49-B290A1600923Q37685428-B5A5BB65-6A9B-450A-AD48-EEE09821C7C8Q37787304-F3C5834F-9EC2-4954-9390-F5D82283027DQ37832963-ACB030EB-3BC7-47AF-8F49-A738E8E2D714Q38197952-B41A1EAC-3918-4417-81DA-690A04CE812EQ41975371-749D02B4-9CDC-4D4C-87F4-02DBB4076F56Q42468577-96883523-7760-43B2-8479-FF8FB75887A8Q42519216-99622EED-0BF2-490C-B21E-E7AB80D8CB91Q42742359-F55963DE-489C-4E9A-AA60-CE34D63D2301Q52148797-59AF2307-CB94-466C-9E7E-E473688BDB57Q55505620-4BD1E74E-CBBB-4D6B-91E2-184D8CC60D39
P2860
Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Histone deacetylase inhibitor ...... mental traumatic brain injury.
@ast
Histone deacetylase inhibitor ...... mental traumatic brain injury.
@en
type
label
Histone deacetylase inhibitor ...... mental traumatic brain injury.
@ast
Histone deacetylase inhibitor ...... mental traumatic brain injury.
@en
prefLabel
Histone deacetylase inhibitor ...... mental traumatic brain injury.
@ast
Histone deacetylase inhibitor ...... mental traumatic brain injury.
@en
P2093
P2860
P356
P1433
P1476
Histone deacetylase inhibitor ...... mental traumatic brain injury.
@en
P2093
Alexander G Alexandrovich
Athanasios Lourbopoulos
Constantina Simeonidou
Eleni Polyzoidou
Esther Shohami
Na'ama A Shein
Nikolaos Grigoriadis
Paolo Mascagni
Victoria Trembovler
P2860
P304
P356
10.1096/FJ.09-134700
P407
P577
2009-09-01T00:00:00Z